Founded with a mission to revolutionize spatial biology, Syncell is a life science technology company that aims to advance the understanding of molecular mechanisms and disease biomarkers. The company's core product, Microscoop™, is an innovative technology that enables microscopy-guided nanoscale protein "scooping," facilitating unbiased subcellular spatial proteomics discovery. Syncell's offerings are designed to address a wide range of biological problems, aiding in the identification of novel disease biomarkers and druggable targets.
Syncell has garnered attention for its groundbreaking approach and has attracted notable investors and industry experts. The company's pioneering work in spatial biology has led to significant achievements, including the development of tools that enhance the precision and scope of proteomics research. Syncell's impact is evident in its contribution to the field of life sciences, providing researchers with powerful new methods to explore and understand complex biological systems.
